Immune Monitor - May 2022

By SITC Communications posted 05-19-2022 00:00

  

A Message from the President

Dear Colleagues,

You could classify me as an immunologist, a doctor, a CEO, but one of my favorite titles is keyboardist for SITC’s house band, The CheckPoints. The band is comprised of thirteen cancer immunotherapy scientists who, in addition to sharing a love of science, have a passion for music. If you haven’t seen The CheckPoints perform yet, I’m happy to let you know you have two upcoming opportunities. The first is next month on Sunday, June 5.  We will be returning to Buddy Guy’s Legends in Chicago! The second opportunity is at the 37th Annual Meeting & Pre-Conference Programs in Boston, MA where the band will play at The CheckPoints Party on Nov. 11.  All proceeds benefit SITC’s Forward Fund which provides much needed funding for our early career scientists. Speaking of the Annual Meeting, registration is officially open! We hope you’ll consider joining us in Boston as we bring together the immunotherapy community for another exceptional meeting. 

This month’s Fireside Chat guest is no stranger to Boston and is a fellow immunologist/ CEO, Dr. Laurie Glimcher. Dr. Glimcher is currently the President and CEO of Dana-Farber Cancer Institute just outside the heart of the city. It was a pleasure to speak with Dr. Glimcher who has achieved so much throughout her career. She is a member of the National Academy of Sciences and the National Academy of Medicine and, notably, she was the first female to be appointed as dean of Weill Cornell Medicine in New York as well as the first female appointed to her current role. 
Our discussion features a number of topics, including the joy of training and mentorship, how taking risks can pay off, balancing a career in science with family life and much more. I hope you all enjoy the conversation as much as I did. Thanks again to Dr. Glimcher for joining for this month’s Fireside Chat.

Sincerely,


Patrick Hwu, MD
SITC President



Join Us in Person at SITC 2022

Join us at the 37th Annual Meeting & Pre-Conference Programs (SITC 2022) taking place Nov. 8–12, 2022, at the Boston Convention and Exhibition Center in Boston, MA. Virtual participation also available at the same registration rates. 

Register today!

Important Dates

  • Now Open: Regular abstracts, Young Investigator Award abstracts and Late-Breaking abstract applications submission site opens
  • July 28, 2022: Regular abstracts, Young Investigator Award abstracts and Late-Breaking abstract applications submission site closes at 5 p.m. PDT
  • Aug. 18, 2022: Late-Breaking abstracts submission site opens  
  • Aug. 30, 2022: Late-Breaking abstracts submission site closes at 5 p.m. PDT
For the full list of important abstract dates, information on abstract categories, guidelines and procedures, FAQs, or to submit your abstract, please visit https://www.sitcancer.org/2022/abstracts2022.

Nominate an Emerging Leader in IO

SITC is pleased to announce the call for nominations for the 2022 Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists. 

The society is seeking the best and brightest to continue Dr. Rosenberg’s legacy with a research award for early career scientists focused on tackling challenges that face the field of cancer immunotherapy. Nominations are due July 15, 2022 and will be accepted via email to development@sitcancer.org.

0 comments
4 views

Related Content

Permalink

https://www.sitcancer.org/blogs/sitc-communications/2022/05/19/immune-monitor-may-2022